Literature DB >> 19665973

The selectivity of receptor tyrosine kinase signaling is controlled by a secondary SH2 domain binding site.

Jae Hyun Bae1, Erin Denise Lew, Satoru Yuzawa, Francisco Tomé, Irit Lax, Joseph Schlessinger.   

Abstract

SH2 domain-mediated interactions represent a crucial step in transmembrane signaling by receptor tyrosine kinases. SH2 domains recognize phosphotyrosine (pY) in the context of particular sequence motifs in receptor phosphorylation sites. However, the modest binding affinity of SH2 domains to pY containing peptides may not account for and likely represents an oversimplified mechanism for regulation of selectivity of signaling pathways in living cells. Here we describe the crystal structure of the activated tyrosine kinase domain of FGFR1 in complex with a phospholipase Cgamma fragment. The structural and biochemical data and experiments with cultured cells show that the selectivity of phospholipase Cgamma binding and signaling via activated FGFR1 are determined by interactions between a secondary binding site on an SH2 domain and a region in FGFR1 kinase domain in a phosphorylation independent manner. These experiments reveal a mechanism for how SH2 domain selectivity is regulated in vivo to mediate a specific cellular process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665973      PMCID: PMC4764080          DOI: 10.1016/j.cell.2009.05.028

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  34 in total

Review 1.  Strategies for macromolecular synchrotron crystallography.

Authors:  W Minor; D Tomchick; Z Otwinowski
Journal:  Structure       Date:  2000-05-15       Impact factor: 5.006

Review 2.  Searching for specificity in SH domains.

Authors:  J E Ladbury; S Arold
Journal:  Chem Biol       Date:  2000-01

Review 3.  Assembly of cell regulatory systems through protein interaction domains.

Authors:  Tony Pawson; Piers Nash
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

4.  Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms.

Authors:  G Waksman; S E Shoelson; N Pant; D Cowburn; J Kuriyan
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

5.  Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism.

Authors:  M Mohammadi; J Schlessinger; S R Hubbard
Journal:  Cell       Date:  1996-08-23       Impact factor: 41.582

Review 6.  Active and inactive protein kinases: structural basis for regulation.

Authors:  L N Johnson; M E Noble; D J Owen
Journal:  Cell       Date:  1996-04-19       Impact factor: 41.582

7.  PDGF stimulation of inositol phospholipid hydrolysis requires PLC-gamma 1 phosphorylation on tyrosine residues 783 and 1254.

Authors:  H K Kim; J W Kim; A Zilberstein; B Margolis; J G Kim; J Schlessinger; S G Rhee
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

8.  Construction of an SH2 domain-binding site with mixed specificity.

Authors:  L Larose; G Gish; T Pawson
Journal:  J Biol Chem       Date:  1995-02-24       Impact factor: 5.157

9.  Structural coupling of SH2-kinase domains links Fes and Abl substrate recognition and kinase activation.

Authors:  Panagis Filippakopoulos; Michael Kofler; Oliver Hantschel; Gerald D Gish; Florian Grebien; Eidarus Salah; Philipp Neudecker; Lewis E Kay; Benjamin E Turk; Giulio Superti-Furga; Tony Pawson; Stefan Knapp
Journal:  Cell       Date:  2008-09-05       Impact factor: 41.582

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  75 in total

1.  Noncanonical tandem SH2 enables interaction of elongation factor Spt6 with RNA polymerase II.

Authors:  Marie-Laure Diebold; Erin Loeliger; Michael Koch; Fred Winston; Jean Cavarelli; Christophe Romier
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

Review 2.  The phospholipase C isozymes and their regulation.

Authors:  Aurelie Gresset; John Sondek; T Kendall Harden
Journal:  Subcell Biochem       Date:  2012

3.  Mechanism of phosphorylation-induced activation of phospholipase C-gamma isozymes.

Authors:  Aurelie Gresset; Stephanie N Hicks; T Kendall Harden; John Sondek
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

4.  Computational tools for the interactive exploration of proteomic and structural data.

Authors:  John H Morris; Elaine C Meng; Thomas E Ferrin
Journal:  Mol Cell Proteomics       Date:  2010-06-04       Impact factor: 5.911

Review 5.  Post-translational modifications in signal integration.

Authors:  Yonathan Lissanu Deribe; Tony Pawson; Ivan Dikic
Journal:  Nat Struct Mol Biol       Date:  2010-05-23       Impact factor: 15.369

6.  SH2 domains recognize contextual peptide sequence information to determine selectivity.

Authors:  Bernard A Liu; Karl Jablonowski; Eshana E Shah; Brett W Engelmann; Richard B Jones; Piers D Nash
Journal:  Mol Cell Proteomics       Date:  2010-07-13       Impact factor: 5.911

7.  Structural basis for the interaction between the growth factor-binding protein GRB10 and the E3 ubiquitin ligase NEDD4.

Authors:  Qingqiu Huang; Doletha M E Szebenyi
Journal:  J Biol Chem       Date:  2010-10-26       Impact factor: 5.157

8.  Src binds cortactin through an SH2 domain cystine-mediated linkage.

Authors:  Jason V Evans; Amanda G Ammer; John E Jett; Chris A Bolcato; Jason C Breaux; Karen H Martin; Mark V Culp; Peter M Gannett; Scott A Weed
Journal:  J Cell Sci       Date:  2012-10-24       Impact factor: 5.285

9.  Deciphering Phosphotyrosine-Dependent Signaling Networks in Cancer by SH2 Profiling.

Authors:  Kazuya Machida; Malik Khenkhar; Peter Nollau
Journal:  Genes Cancer       Date:  2012-05

10.  Itk tyrosine kinase substrate docking is mediated by a nonclassical SH2 domain surface of PLCgamma1.

Authors:  Lie Min; Raji E Joseph; D Bruce Fulton; Amy H Andreotti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.